Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Laura Bertolaccini

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Journal of Autoimmunity|May 11, 2016
Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndromeMaria Laura Bertolaccini, Gregorio Contento, Ross Lennen, et al.
Thrombosis and Haemostasis|September 30, 2003
Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significanceMaria Laura Bertolaccini, Giovanni Sanna, Shvaita Ralhan, et al.
The Journal of Rheumatology|September 3, 2017
Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of "Non-criteria" Antiphospholipid AntibodiesNavid Zohoury, Maria Laura Bertolaccini, Jose Luis Rodriguez-Garcia, et al.
Journal of Thrombosis and Haemostasis : JTH|November 7, 2024
An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid AntibodiesKatrien M J Devreese, Maria Laura Bertolaccini, D Ware Branch, et al.
Rheumatology (Oxford, England)|December 17, 2019
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patientsSavino Sciascia, Massimo Radin, Irene Cecchi, et al.
Autoimmunity Reviews|January 3, 2024
Deciphering the clinical significance of longitudinal antiphospholipid antibody titersCecilia B Chighizola, Rohan Willis, Gabriella Maioli, et al.
Blood|April 25, 2012
Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q(10) treatmentCarlos Perez-Sanchez, Patricia Ruiz-Limon, Maria Angeles Aguirre, et al.
Annals of the Rheumatic Diseases|March 25, 2014
Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatmentPatricia Ruiz-Limon, Nuria Barbarroja, Carlos Perez-Sanchez, et al.
Autoimmunity Reviews|May 15, 2014
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trendsMaria Laura Bertolaccini, Olga Amengual, Laura Andreoli, et al.
Rheumatology (Oxford, England)|June 13, 2026
Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with antiphospholipid antibodies: an APS ACTION Registry studyIbrahim Tohidi-Esfahani, Veronica Venturelli, Maria Tektonidou, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Journal of Autoimmunity|May 11, 2016
Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndromeMaria Laura Bertolaccini, Gregorio Contento, Ross Lennen, et al.
Thrombosis and Haemostasis|September 30, 2003
Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significanceMaria Laura Bertolaccini, Giovanni Sanna, Shvaita Ralhan, et al.
The Journal of Rheumatology|September 3, 2017
Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of "Non-criteria" Antiphospholipid AntibodiesNavid Zohoury, Maria Laura Bertolaccini, Jose Luis Rodriguez-Garcia, et al.
Journal of Thrombosis and Haemostasis : JTH|November 7, 2024
An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid AntibodiesKatrien M J Devreese, Maria Laura Bertolaccini, D Ware Branch, et al.
Rheumatology (Oxford, England)|December 17, 2019
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patientsSavino Sciascia, Massimo Radin, Irene Cecchi, et al.
Autoimmunity Reviews|January 3, 2024
Deciphering the clinical significance of longitudinal antiphospholipid antibody titersCecilia B Chighizola, Rohan Willis, Gabriella Maioli, et al.
Blood|April 25, 2012
Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q(10) treatmentCarlos Perez-Sanchez, Patricia Ruiz-Limon, Maria Angeles Aguirre, et al.
Annals of the Rheumatic Diseases|March 25, 2014
Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatmentPatricia Ruiz-Limon, Nuria Barbarroja, Carlos Perez-Sanchez, et al.
Autoimmunity Reviews|May 15, 2014
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trendsMaria Laura Bertolaccini, Olga Amengual, Laura Andreoli, et al.
Rheumatology (Oxford, England)|June 13, 2026
Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with antiphospholipid antibodies: an APS ACTION Registry studyIbrahim Tohidi-Esfahani, Veronica Venturelli, Maria Tektonidou, et al.
Pageof 7